paclitaxel has been researched along with Angina at Rest in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (65.22) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baber, U; Camenzind, E; Chieffo, A; Dangas, GD; Faggioni, M; Farhan, S; Galatius, S; Giustino, G; Harari, R; Itchhaporia, D; Jeger, RV; Kandzari, D; Kastrati, A; Kim, HS; Kimura, T; Leon, MB; Mehran, R; Mehta, L; Morice, MC; Sartori, S; Serruys, PW; Sharma, M; Smits, PC; Sorrentino, S; Stefanini, GG; Steg, PG; Stone, GW; Valgimigli, M; Von Birgelen, C; Weisz, G; Wijns, W; Windecker, S | 1 |
| Ashikaga, T; Fukushima, T; Hatano, Y; Isobe, M; Ueshima, D; Yamamoto, T; Yasuhiro, M; Yoshikawa, S | 1 |
| Eränen, J; Kärkkäinen, JM; Mäntylä, P; Mustonen, J; Rissanen, TT; Siljander, A; Uskela, S | 1 |
| Allocco, D; Dawkins, KD; Ellis, SG; Guagliumi, G; Jiang, S; Kobayashi, N; Maehara, A; McAndrew, TC; Mintz, GS; Ormiston, JA; Stone, GW; Turco, MA; Weissman, NJ; Witzenbichler, B | 1 |
| Berti, S; Ciardetti, M; Coceani, M; Palmieri, C; Pastormerlo, LE; Ravani, M; Rizza, A; Shlueter, M; Trianni, G; Vaghetti, M | 1 |
| Baliulis, G; Corbett, S; Curzen, N; Kaarne, M; Olsen, S; Rawlins, J; Roubelakis, A | 1 |
| Jones, HR; Srinivasan, J | 1 |
| Lanjewar, CP; Sharma, A; Sheth, T | 1 |
| Barlis, P; Garcia-Garcia, HM; Gonzalo, N; Ligthart, J; Onuma, Y; Regar, E; Serruys, PW | 1 |
| Chen, F; Chen, JG; Chen, SL; Liu, ZZ; Luo, WP; Shan, SJ; Sun, XW; Xu, YW; Yang, S; Ye, F; Zhang, AP; Zhang, JJ | 1 |
| Endoh, A; Imai, K; Ishikawa, T; Kubota, T; Miyamoto, T; Mochizuki, S; Murakami, M; Mutoh, M; Nakano, Y; Nakata, K; Sakamoto, H; Suzuki, T; Yoshimura, M | 1 |
| Applegate, RJ; Cao, S; Hermiller, JB; Lansky, AJ; Nikolsky, E; Sanz, M; Sood, P; Stone, GW; Sudhir, K; Yaqub, M | 1 |
| Dean, L; Hazan, M; Vassilev, D | 1 |
| Chaikin, P; Durrleman, S | 1 |
| Ellis, SG; Kimmelstiel, C; Kosinski, E; Leon, MB; McGarry, TF; Mehran, R; Mishkel, GJ; Nikolsky, E; Russell, ME; Stone, GW | 1 |
| Banning, AP; Porto, I | 1 |
| Aoki, J; de Feyter, PJ; de Jaegere, PP; McFadden, EP; Ong, AT; Regar, E; Rodriguez Granillo, GA; Serruys, PW; Sianos, G; Sonnenschein, K; Tsuchida, K; Valgimigli, M; van der Giessen, WJ; van Domburg, RT; van Mieghem, CA | 1 |
| Chang, M; Dangas, G; Ellis, SG; Kao, J; Laufer, N; Mehran, R; Russell, ME; Stone, GW; Tannenbaum, MA; Teirstein, PS; Watkins, M | 1 |
| Abizaid, A; Missel, E; Sousa, A; Sousa, JE | 1 |
| Tanabe, K | 1 |
| Avanzas, P; Lopez-Palop, R; Lozano, I; Moris, C; Rondan, J; Vegas, JM | 1 |
| Daemen, J; Erdman, RA; Pedersen, SS; Serruys, PW; Sonnenschein, K; van de Sande, M; van Domburg, RT | 1 |
1 review(s) available for paclitaxel and Angina at Rest
| Article | Year |
|---|---|
[Technical evolution of the stent].
Topics: Angina, Unstable; Animals; Clinical Trials as Topic; Coronary Restenosis; Drug Delivery Systems; Humans; Myocardial Infarction; Paclitaxel; Prognosis; Sirolimus; Stents; Syndrome | 2006 |
5 trial(s) available for paclitaxel and Angina at Rest
| Article | Year |
|---|---|
Different edge effects of paclitaxel- and sirolimus-eluting stents on proximal and distal edges in patients with unstable angina: serial intravascular ultrasound analysis.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Coronary Angiography; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Treatment Outcome; Ultrasonography | 2009 |
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Laser-Assisted; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Incidence; Longitudinal Studies; Male; Myocardial Ischemia; Paclitaxel; Risk Factors; Sirolimus; Treatment Outcome | 2011 |
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Body Mass Index; Coronary Angiography; Coronary Disease; Coronary Restenosis; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Ischemia; Obesity; Paclitaxel; Polymers; Proportional Hazards Models; Risk Factors; Stents | 2005 |
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Creatine Kinase; Creatine Kinase, MB Form; Double-Blind Method; Drug Interactions; Eptifibatide; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Isoenzymes; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Paclitaxel; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2005 |
Are paclitaxel-eluting stents safe and effective in patients with acute coronary syndromes?
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Restenosis; Double-Blind Method; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Radiography; Risk Assessment; Stents; Survival Rate; Treatment Outcome | 2005 |
17 other study(ies) available for paclitaxel and Angina at Rest
| Article | Year |
|---|---|
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Non-ST Elevated Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Sirolimus; ST Elevation Myocardial Infarction; Treatment Outcome | 2017 |
Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Tomography, Optical Coherence; Tubulin Modulators | 2018 |
Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Paclitaxel; Registries; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome | 2019 |
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
Topics: Aged; Angina, Stable; Angina, Unstable; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Tubulin Modulators; Ultrasonography, Interventional | 2014 |
Drug eluting balloon: a multipurpose tool for coronary revascularization with optimal long-term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Registries | 2014 |
Coronary artery rupture caused by stent infection: a rare complication.
Topics: Angina, Unstable; Anti-Bacterial Agents; Chest Pain; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Emergencies; Floxacillin; Fusidic Acid; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis-Related Infections; Rupture, Spontaneous; Staphylococcal Infections; Ultrasonography; Ventricular Dysfunction, Left | 2015 |
Sensory polyneuropathy associated with paclitaxel-eluting coronary stent.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon; Coronary Restenosis; Disease Susceptibility; Drug-Eluting Stents; Humans; Male; Neural Conduction; Paclitaxel; Paresthesia; Polyneuropathies; Recurrence; Sensation Disorders; Sjogren's Syndrome | 2009 |
IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Aneurysm; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Retreatment; Ultrasonography, Interventional | 2009 |
Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/un
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Factors; Sirolimus; Tomography, Optical Coherence | 2009 |
Drug-eluting coronary stents: many meta-analyses, little benefit.
Topics: Angina, Unstable; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome | 2009 |
Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: a retrospective comparison with western mega-studies.
Topics: Acute Coronary Syndrome; Angina, Unstable; Clinical Trials as Topic; Drug-Eluting Stents; Europe; Humans; Incidence; Japan; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Sirolimus; Thrombosis; Ticlopidine; United States | 2009 |
Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: first case report.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Cardiac Catheters; Cardiovascular Agents; Clopidogrel; Coronary Aneurysm; Coronary Angiography; Coronary Restenosis; Drug Delivery Systems; Drug Therapy, Combination; Drug-Eluting Stents; Equipment Design; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors | 2012 |
The use of putative placebo in active control trials: two applications in a regulatory setting.
Topics: Angina, Unstable; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase III as Topic; Confidence Intervals; Data Interpretation, Statistical; Docetaxel; Doxorubicin; Enoxaparin; Female; Fibrinolytic Agents; Humans; Myocardial Infarction; Odds Ratio; Paclitaxel; Placebos; Randomized Controlled Trials as Topic; Taxoids; Therapeutic Equivalency | 2003 |
Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Topics: Adult; Angina, Unstable; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Restenosis; Follow-Up Studies; Humans; Magnetic Resonance Angiography; Male; Paclitaxel; Risk Assessment; Sirolimus; Stents; Treatment Failure; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency | 2005 |
Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries).
Topics: Aged; Angina, Unstable; Diabetes Complications; Female; Humans; Immunosuppressive Agents; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Proportional Hazards Models; Prospective Studies; Registries; Sirolimus; Stents; Treatment Outcome | 2005 |
Drug eluting stents may not be the answer for myocardial bridges.
Topics: Angina, Unstable; Antineoplastic Agents, Phytogenic; Coronary Restenosis; Coronary Vessel Anomalies; Drug Delivery Systems; Humans; Male; Middle Aged; Paclitaxel; Stents | 2007 |
Type-D personality exerts a stable, adverse effect on vital exhaustion in PCI patients treated with paclitaxel-eluting stents.
Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Personality Inventory; Risk Factors; Sex Factors; Stents | 2007 |